|Novamind to Present at Life Sciences Investor Forum|
|By GLOBE NEWSWIRE|
|Wednesday, 15 September 2021 03:35|
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE)
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Novamind Inc. (CSE: NM | OTCQB: NVMDF | FSE: HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce its participation in the Life Sciences Investor Forum, taking place virtually on Thursday, September 16 at 12:00 PM EST.
Join Novamind’s Chief Medical Officer and Director, Dr. Reid Robison, live as he presents the Company’s model for scaling access to psychedelic medicine through a multi-state, U.S. expansion of leading psychiatry clinics and clinical research sites. Investors are invited to participate in an open Q&A session following the presentation.
An archived webcast will be made available for attendees who are not able to join the event live.
Click here to join the webcast.
Contact Information Novamind Yaron Conforti, CEO and Director Telephone: +1 (647) 953 9512 Samantha DeLenardo, VP, Communications Email: [email protected] Bill Mitoulas, Investor Relations Email: [email protected]